These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 9037478)
1. Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment. Selley DE; Nestler EJ; Breivogel CS; Childers SR Brain Res; 1997 Jan; 746(1-2):10-8. PubMed ID: 9037478 [TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes. Breivogel CS; Selley DE; Childers SR J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416 [TBL] [Abstract][Full Text] [Related]
3. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Liu JG; Prather PL Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600 [TBL] [Abstract][Full Text] [Related]
4. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238 [TBL] [Abstract][Full Text] [Related]
5. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors. Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Yabaluri N; Medzihradsky F Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981 [TBL] [Abstract][Full Text] [Related]
7. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor. Xu H; Wang X; Wang J; Rothman RB Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220 [TBL] [Abstract][Full Text] [Related]
8. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling. Wang HY; Friedman E; Olmstead MC; Burns LH Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657 [TBL] [Abstract][Full Text] [Related]
9. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. Sim LJ; Selley DE; Childers SR Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7242-6. PubMed ID: 7638174 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532 [TBL] [Abstract][Full Text] [Related]
11. Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate autoradiography in rat brain. Kirschke C; Schadrack J; Zieglgänsberger W; Spanagel R Eur J Pharmacol; 2002 Jun; 446(1-3):43-51. PubMed ID: 12098584 [TBL] [Abstract][Full Text] [Related]
12. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor. Zhang D; Li JG; Chen C; Liu-Chen LY Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435 [TBL] [Abstract][Full Text] [Related]
13. Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions. Maher CE; Selley DE; Childers SR Biochem Pharmacol; 2000 Jun; 59(11):1395-401. PubMed ID: 10751548 [TBL] [Abstract][Full Text] [Related]
14. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Traynor JR; Nahorski SR Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747 [TBL] [Abstract][Full Text] [Related]
15. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. Noble F; Cox BM Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358 [TBL] [Abstract][Full Text] [Related]
16. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Selley DE; Sim LJ; Xiao R; Liu Q; Childers SR Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350 [TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists. Kramer HK; Simon EJ J Neurochem; 1999 Feb; 72(2):585-93. PubMed ID: 9930730 [TBL] [Abstract][Full Text] [Related]
18. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections. Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153 [TBL] [Abstract][Full Text] [Related]